SLC39A13 Defines Myofibroblastic Activation and Immunosuppressive Tumor Microenvironment in Head and Neck Squamous Cell Carcinoma
Open Access
- 18 May 2026
- journal article
- research article
- Published by MDPI AG in Current Oncology
- Vol. 33 (5) , 292
Abstract
Zinc transport plays a critical role in cellular signaling, but its function in the tumor microenvironment remains poorly understood. We aimed to investigate the role of zinc transporters in cancer-associated fibroblasts in head and neck squamous cell carcinoma. Single-cell RNA sequencing data were analyzed to evaluate zinc transporter expression across tumor cell populations, and bulk RNA sequencing of primary fibroblast cultures was used for validation. Clinical relevance was assessed using transcriptomic and survival data from a large patient cohort. We found that zinc transporter expression, particularly SLC39A13, was enriched in fibroblasts and strongly associated with myofibroblastic activation signatures, including extracellular matrix remodeling and TGFβ signaling. Fibroblasts with high SLC39A13 expression were linked to immunosuppressive tumor environments characterized by reduced cytotoxic T-cell infiltration and increased immunosuppressive cells. Clinically, SLC39A13 expression was associated with poor progression-free survival and remained an independent prognostic factor. These findings suggest that zinc transporter-mediated pathways play a key role in stromal activation and immune regulation, highlighting SLC39A13 as a potential therapeutic target in head and neck squamous cell carcinoma.Keywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology (25K12735)
- Ministry of Education, Culture, Sports, Science and Technology (25K02785)
- Ministry of Education, Culture, Sports, Science and Technology (20H03834)
This publication has 46 references indexed in Scilit:
- Roles of zinc in cancers: From altered metabolism to therapeutic applicationsInternational Journal of Cancer, 2023
- Tumor microenvironment in head and neck squamous cell carcinoma: Functions and regulatory mechanismsCancer Letters, 2021
- Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 studyThe Lancet, 2019
- Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Head and Neck CancerCell, 2017
- Immunosuppressive activity of cancer-associated fibroblasts in head and neck squamous cell carcinomaCancer Immunology, Immunotherapy, 2015
- Zinc signals and immune functionBioFactors, 2013
- Zinc homeostasis and signaling in health and diseasesJBIC Journal of Biological Inorganic Chemistry, 2011
- The myofibroblast: Paradigm for a mechanically active cellJournal of Biomechanics, 2010
- Zinc transporters and cancer: a potential role for ZIP7 as a hub for tyrosine kinase activationTrends in Molecular Medicine, 2009
- Zinc as an anti-tumor agent in prostate cancer and in other cancersArchives of Biochemistry and Biophysics, 2007